ClinicalTrials.Veeva

Menu

Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain

Pfizer logo

Pfizer

Status and phase

Terminated
Phase 2

Conditions

Post-surgical Dental Pain

Treatments

Drug: Ibuprofen
Other: Placebo
Drug: PF-04531083

Study type

Interventional

Funder types

Industry

Identifiers

NCT01512160
B1351010

Details and patient eligibility

About

The purpose of this study is to evaluate the overall pain relief of a single dose of PF-04531083 against placebo following third molar extraction.

Enrollment

90 patients

Sex

Male

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Oral surgical procedure having removed 2 third molars (unilateral).
  • Pre-dose pain intensity score (100 mm Visual Analog Scale [VAS]) >50 mm within 5 hours of oral surgery.
  • Pre-dose pain intensity score of moderate or within 5 hours of oral surgery.

Exclusion criteria

  • Presence or history of any significant hepatic, renal, endocrine, cardiovascular, neurological (including subjects with a history of frequent moderate to severe headaches or subjects with episodic migraines more than twice per month), psychiatric, gastrointestinal, pulmonary, hematologic, or metabolic disorder.
  • Prior use of any type of analgesic or NSAID within five half-lives of that drug or less before taking the first dose of study medication, except for anesthesia for the procedure.
  • Recent history of chronic analgesic or tranquilizer dependency.
  • Active dental infection at the time of surgery.
  • Any significant oral surgery complication at the time of surgery or in the immediate postoperative period or dental surgery lasting > 30 minutes.
  • Subjects who are smokers.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 4 patient groups, including a placebo group

PF-04531083 2000 mg
Experimental group
Treatment:
Other: Placebo
Drug: PF-04531083
Drug: PF-04531083
Other: Placebo
Other: Placebo
Other: Placebo
Other: Placebo
PF-04531083 1000 mg
Experimental group
Treatment:
Other: Placebo
Drug: PF-04531083
Drug: PF-04531083
Other: Placebo
Other: Placebo
Other: Placebo
Other: Placebo
Ibuprofen 400 mg
Active Comparator group
Treatment:
Other: Placebo
Drug: Ibuprofen
Other: Placebo
Other: Placebo
Other: Placebo
Other: Placebo
Placebo
Placebo Comparator group
Treatment:
Other: Placebo
Other: Placebo
Other: Placebo
Other: Placebo
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems